What is Progyny's market cap?

Progyny (PGNY) has a market capitalization of $2.5B and trades on NASDAQ.

What is Progyny's revenue and profitability?

Progyny generated $1.3B in trailing twelve-month revenue with net income of $67.7M, representing a net margin of 5.2%. Gross margin stands at 24.1%, with free cash flow of $184.4M. These figures are based on the Q1 2026 filing.

Who are Progyny's competitors?

Progyny's key competitors include UnitedHealth Group, CVS Health, Femasys Inc. Common Stock, and others. These companies compete in similar markets and product categories.

Where is Progyny headquartered?

Progyny is headquartered in United States of America and employs approximately 566 people. It has been publicly traded since 2019.

Progyny

PGNY

Progyny is a leading provider of specialized healthcare benefits solutions focused on women's health and family building.

Market cap

$2.47B+22.8%

Revenue$1.3B+6.6%

Net income$67.7M+29.0%

Free cash flow$184.4M-5.8%

EPS (diluted)$0.77+35.1%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$328.5MBeat by $2.0M EPS$0.29Beat by $0.03

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$348.6M

EPS estimate$0.34

Financials

Q1 2026

Income statement

See full

Revenue$328.5M+1.4%

Gross profit$83.1M+9.6%

Operating income$35.4M+46.4%

Net income$24.2M+60.9%

EPS (diluted)$0.29+70.6%

Balance sheet

See full

Cash & equivalents$131.6M+20.5%

Total debt$27.3M-5.6%

Total equity$439.3M-6.0%

Total assets$698.3M-4.4%

Cash flow

See full

Operating cash flow$45.9M-7.7%

CapEx$6.3M+123%

Free cash flow$39.6M-15.7%

Valuation & ratios

Valuation

See full

Market cap$2.47B+22.8%

Enterprise value$2.37B+25.8%

P/E36.6×-0.9×

P/S1.9×+0.3×

Profitability

See full

Gross margin24.1%+2.1pp

Operating margin7.5%+1.4pp

Net margin5.2%+0.9pp

FCF margin14.3%-1.9pp

Returns & leverage

See full

Return on equity14.9%+4.8pp

Debt / equity0.1×0.0×

Current ratio2.1×-0.3×

Segments

By product

See full

Fertility benefits services revenue$209.4M+1.5%

Pharmacy benefits services revenue$119.1M+1.2%

By segment

See full

Reportable segment$328.5M+1.4%

Competitors

By market cap

UnitedHealth Group$379.28B+48.2%

CVS Health$136.61B+81.1%

Natera, Inc.$37.0B+96.1%

Organon$3.6B+37.2%

Progyny$2.5B+24.4%

Sera Prognostics$80.3M-32.1%

INVO Fertility, Inc.$1.7M-13.4%

Femasys$440.9K-98.4%

By revenue growth

Natera, Inc.+36.6%

UnitedHealth Group+9.7%

CVS Health+7.6%

Progyny+6.6%

Organon-2.1%

Sera Prognostics-50.4%

By net margin

Organon7.95%-5.0pp

Progyny5.23%+0.9pp

UnitedHealth Group2.68%-2.7pp

CVS Health0.719%-0.7pp

Natera, Inc.-14.61%-3.2pp

Sera Prognostics-56,385.96%-27,701pp

Profile

Progyny is a leading provider of specialized healthcare benefits solutions focused on women's health and family building. The company offers a data-driven platform that connects employees of large organizations to a premier network of fertility specialists and comprehensive clinical support. Their core value proposition centers on improving clinical outcomes, such as higher pregnancy rates and lower miscarriage rates, while reducing overall healthcare costs for self-insured employers.

Competitive position

Progyny is a market leader in the fertility benefits space, distinguished by its proprietary Smart Cycle model and a network that includes 45 of the top 50 fertility practice groups in the U.S.

GeographiesUnited States, Global

Customer segmentsEnterprise, Government, Labor Unions

Business modelB2B2C, Fee-for-service, Platform-as-a-Service

SuppliersFertility specialists and clinics, Reproductive endocrinologists, Pharmaceutical manufacturers, Specialty pharmacies

CustomersFortune 500 companies, Self-insured enterprise employers, Public sector entities, Labor unions

CountryUnited States of America

Listed2019

Employees566.0

CEOPete Anevski

SectorHealthcare

IndustryMedical - Healthcare Information Services

Websiteprogyny.com

FilingsSEC EDGAR

Ask your AI about Progyny.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Progyny's market cap?: Progyny (PGNY) has a market capitalization of $2.5B and trades on NASDAQ.
What is Progyny's revenue and profitability?: Progyny generated $1.3B in trailing twelve-month revenue with net income of $67.7M, representing a net margin of 5.2%. Gross margin stands at 24.1%, with free cash flow of $184.4M. These figures are based on the Q1 2026 filing.
Who are Progyny's competitors?: Progyny's key competitors include UnitedHealth Group, CVS Health, Femasys Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Where is Progyny headquartered?: Progyny is headquartered in United States of America and employs approximately 566 people. It has been publicly traded since 2019.